SynthesisBMC cancer2011

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.

Bin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.